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ABSTRACT

Macrophages contribute to plaque formation in atherosclerosis. Macrophages take up
modified low-density lipoproteins and store excess cholesterol and triglycerides in lipid
droplet organelles. Evidence of lipid-laden macrophages or “foam cells” is apparent on
histology sections of diseased arteries, and this lipid-laden appearance can be recreated in
cell culture upon exposure of cultured macrophages to acetylated LDL (Ac-LDL). Under
nutrient stress, neutral lipids in lipid droplets are hydrolyzed by lipolysis, autophagy, or
both. However, these processes are not well understood in macrophages. We created lipidladen macrophages by 24-h exposure to Ac-LDL and analyzed dynamics of lipid droplet
metabolism following removal of Ac-LDL from cell culture medium. We found that lipid
droplets in these macrophages are cleared within 24 h of Ac-LDL removal from the
medium. We then analyzed co-localization of adipophilin, a lipid droplet marker, and LC3,
an autophagy marker, with lipid droplets. Results from induction of autophagy by
rapamycin, and inhibition of autophagosome formation by 3-methyl adenine suggests the
involvement of autophagy in lipid droplet disappearance from cells in the absence of AcLDL in the culture media. Studying the mechanisms of lipid droplet degradation will allow
us to understand how lipid droplets could be cleared from foam cells resident in
atherosclerotic plaques and identify potential therapeutic targets for treating
atherosclerosis.
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CHAPTER ONE
LITERATURE REVIEW
INTRODUCTION
Heart attack is the leading cause of death in U.S. and kills more than 600,000 people
each year (Benjamin, Blaha et al. 2017). The pathological condition responsible for heart
attack is known as atherosclerosis. The formation of plaque in the arterial walls causes
constriction of blood vessels. Rupture of the plaque and subsequent clot formation blocks
the flow of oxygen-rich blood and starves the heart muscle of oxygen, causing “heart
attack.”
Lipid-laden macrophages or foam cells are the hallmark of atherosclerosis (Stary,
Chandler et al. 1994, Bobryshev 2006). Increased uptake of modified low-density
lipoprotein (LDL) and/or reduced cholesterol efflux leads to the formation of intracellular
organelles called lipid droplets. Macrophages with excessive lipid droplets are known as
foam cells (Yu, Fu et al. 2013). These cells contribute to the plaque formation in
atherosclerosis (Ross 1999). Lipolysis and lipophagy (Kovsan, Bashan et al. 2010) are the
two known mechanisms for metabolism of lipid droplets. However, lipid droplet
metabolism in macrophages is not clearly understood. Understanding the mechanisms of
degradation of lipid droplets in macrophages is important in to find therapeutic target for
the treatment of atherosclerosis.
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FOAM CELLS IN ATHEROSCLEROSIS
Monocyte recruitment
Macrophages play a key role in the initiation and progression of atherosclerosis.
Recruitment of monocytes to the intima of the artery wall and differentiation into
macrophages is the early stage of plaque formation in atherosclerosis. Uncontrolled uptake
of modified low-density lipoprotein (LDL) by macrophages and defective cholesterol
transport leads to the formation of lipid droplets and subsequent formation of foam cells
(Feng and Tabas 2002).

Cholesterol uptake
Cholesterol uptake in the form of modified low-density lipoprotein (LDL) is
considered the earliest stage of foam cell formation. Macrophages can take up
apolipoprotein B (APOB) containing lipoproteins via LDL receptors (LDLR) (Moore,
Sheedy et al. 2013). However, during early stages of foam cell formation those receptors
get downregulated in response to increased intracellular cholesterol levels. This gave rise
to the idea that LDLs might be modified in some ways and endocytosed by macrophages
through other non-LDLR mechanisms.
Chemical modifications to LDL include oxidation and acetylation and lead to
alternative routes of uptake by macrophages. Increased oxidative stress leads to LDL
modifications that generate damaged signals which recognized by pattern recognition
receptors on immune cells (Moore, Sheedy et al. 2013). This idea came from work in
which oxidized epitopes of LDLs were detected in human and mouse atheroma by natural
antibodies (Miller, Choi et al. 2011). In the arterial wall, LDLs can also be oxidized by
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enzymes such as 12/15-lipoxygenase, myeloperoxidase, and free radicals such as
superoxide, hydrogen peroxide, nitric oxide (Miller, Choi et al. 2011).
Macrophages express scavenger receptors such as pattern recognition receptors
which can recognize and process modified LDLs and take part in atherosclerosis (Moore
and Freeman 2006). This scavenger receptor family includes scavenger receptor A (SRA),
macrophage receptor with collagenous receptor (MARCO), cluster of differentiation 36
(CD36) (Sun, Boyanovsky et al. 2007), scavenger receptor class B member 1 (SRB1) (Sun,
Boyanovsky et al. 2007), lectin-type oxidized low-density lipoprotein receptor 1 (LOX1)
(Chen, Masaki et al. 2002), scavenger receptor class E member 1 (SREC1) and scavenger
receptor for phosphatidylserine and oxidized low-density lipoprotein (Shimaoka, Kume et
al. 2000) which are responsible for binding to oxidized LDL and formation of foam cells.
Among these receptors, scavenger receptor A (SRA) and CD36 are responsible for 75-90%
degradation of acetylated or oxidized LDLs in vitro (Kunjathoor, Febbraio et al. 2002).
These receptors internalize modified low-density lipoproteins by receptor mediated
endocytosis.

Cholesterol esterification and re-esterification cycle
The balance of free cholesterols and cholesterol esters is critical for overall
cholesterol content in macrophage foam cells. After internalization of modified LDLs,
macrophages process those in late endosomes or lysosomes (Goldstein, Dana et al. 1975).
This is the organelle where lysosomal acid lipases hydrolyze cholesterol esters to produce
free cholesterols (Goldstein, Dana et al. 1975). Free cholesterols are toxic for cells. To
prevent cell toxicity, released free cholesterols from lysosomes are re-esterified in
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endoplasmic reticulum by acyl co-enzyme A: cholesterol acyltransferase 1 (ACAT 1). Reesterified cholesterols are then stored in cytoplasmic lipid droplets (Chistiakov, Bobryshev
et al. 2016). The re-esterification process by ACAT1 is opposed by neutral cholesterol ester
hydrolase which hydrolyze cholesterol esters for efflux out of cells. When ACAT1 activity
dominates over neutral cholesterol esters activity, macrophages get filled up with
cholesterol esters and turn into foam cells.

Cholesterol efflux
Cholesterol efflux is the first step of reverse cholesterol transport. Macrophages can
respond to cholesterol ester accumulation by passing cholesterol through transporters or
passive diffusion to extracellular high-density lipoprotein (HDL) or apolipoprotein A1.
Several transporters known as ATP-binding cassette transporter A family member 1
(ABCA1), ATP-binding cassette transporter A family member 1 (ABCG1) and scavenger
receptor B family member 1 (SRB1) help facilitate cholesterol efflux from macrophages.
In vivo study of atherosclerosis in mice revealed that expression of both ABCA1 and
ABCG1 are important for cholesterol efflux and preventing foam cell formation (YvanCharvet, Ranalletta et al. 2007). ATP binding cassette transporter A1 associates with
apolipoprotein A1 to facilitate cholesterol efflux out of cells (Wang, Silver et al. 2000).
Whereas, ATP binding cassette transporter G1 transports cholesterol to high density
lipoprotein (Wang, Lan et al. 2004).
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LIPID DROPLETS
Structure & composition of lipid droplets
Lipid droplets are round structures of 0.1-5 µm in diameter in non-adipocytes and
can be up to 100 µm in white adipocytes (Fujimoto and Parton 2011). Lipid droplets are
composed of neutral lipids such as triglycerides, cholesterol and cholesteryl esters
surrounded by a phospholipid mono-layer (Tauchi-Sato, Ozeki et al. 2002, Bartz, Li et al.
2007). The membrane of lipid droplets contains numerous different proteins, of which the
majority are structural proteins in the perilipin family (Brasaemle 2007). Some lipid
synthesis enzymes such as acetyl coenzyme A (CoA) carboxylase, acyl-CoA synthetase
and acyl-CoA:diacylglycerol acyltransferase 2 (DGAT2) (Kuerschner, Moessinger et al.
2008); lipases such as adipose tissue triacylglycerol lipase; and membrane-trafficking
proteins like small GTPase Rab family proteins are also found on lipid droplets
(Kuerschner, Moessinger et al. 2008). Based on the composition, intracellular lipid droplets
are predominantly divided into triglyceride-rich lipid droplets and cholesteryl ester-rich
lipid droplets in mammalian cells. Different compositions of lipid droplets depend on the
tissue that accumulates lipid droplets and the metabolic function of that tissue (Khor,
Ahrends et al. 2014). In adipocytes, lipid droplets are predominantly composed of
triglycerides, but in most cells types both triglycerides and cholesteryl esters coexist in
various ratios. Even though no demarcation is found in the lipid droplet core under electron
microscope, in some circumstances at least triglycerides and cholesterol esters may be
segregated from each other (Czabany, Wagner et al. 2008, Cheng, Fujita et al. 2009).
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Lipid droplet associated proteins
Lipid droplet associated proteins are known as PAT proteins and consist of perilipin,
adipophilin and TIP4 proteins. In mammals, the PAT family has five members: perilipin 1
(PLIN1), perilipin 2 (PLIN2/adipophilin/adipose differentiation-related protein/ADFP),
perilipin 3 (PLIN3/Tip47), perilipin 4 (PLIN4/S3-12), and perilipin 5 (PLIN5/lipid storage
droplet protein 5/myocardial lipid droplet protein/OXPAT/PAT1) (Bickel, Tansey et al.
2009). Different cell types have different lipid droplets. Different types of lipid droplets
are distinguished based on protein composition. Even in the same cell, different sized lipid
droplets have different proteins on them. In macrophage foam cells, perilipin 2 or
adipophilin are predominantly associated with lipid droplets (Paul, Chang et al. 2008).

AUTOPHAGY
Autophagy is an ancient process that plays an important role in the degradation of
cellular organelles. Under starvation condition, it delivers cellular constituents to the lytic
compartments of cells. Through this process, cells can degrade damaged organelles as well
as serve to combat infection by different kinds of pathogens (Swanson, Byrne et al. 2009).
There are three kinds of autophagy: 1) chaperone-mediated autophagy in which molecular
chaperones recognizes single proteins and delivers them to lysosomes for degradation; 2)
micro-autophagy in which lysosomes internalize cellular constituents by invaginating and
pinching off lysosomal membranes to the core; and 3) macro-autophagy, where a de-novo
organelle named auto-phagosomes are formed surrounding damaged organelles
(Ravikumar, Futter et al. 2009). Those auto-phagosomes then fuse with lysosomes to
deliver damaged organelles for degradation (Singh and Cuervo 2011).
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Macro-autophagy
As described above, autophagosomes are formed in macroautophagy to deliver
degradative organelles to lysosomes. Macroautophagy is a multistep process. It starts from
phagophore initiation and ends through the degradation of the organelle.

Initiation of auto-phagosome formation
In mammals, macroautophagy initiates with the formation of autophagosomes.
Autophagosome formation is associated with the development of a kinase complex that is
formed by beclin, Vps34, and Vps15 and different modulatory proteins to the organelle
membranes. The kinase complex together with the delivery of lipids and continuous
shuttling of Atg9 forms isolation membranes. The isolation membrane is also called the
phagophore. The phagophore membrane mostly originates from the mitochondria (Hailey,
Rambold et al. 2010), endoplasmic reticulum (Hayashi-Nishino, Fujita et al. 2009), transGolgi network (Tooze and Yoshimori 2010), late endosomes (Longatti and Tooze 2012),
and plasma membrane (Ravikumar, Moreau et al. 2010). Elongation of the phagophore is
an important stage of autophagosome formation. Two ubiquitin-like conjugation systems
such as the Atg12-Atg5-Atg16 system and microtubule-associated protein 1 light chain 3
(LC3) system or Atg8 are required for the elongation and maturation of autophagosomes
(Kaufmann, Beier et al. 2014). In Atg12-Atg5-Atg16 system, Atg12 is first evolved by
Atg7 in an ATP-dependent mechanism. Atg12 is then transferred to Atg7 to form an
intermediate complex Atg12-Atg10. After being covalently attached to Atg5, Atg12-Atg5
complex further interacts with Atg16 homodimer to produce Atg12-Atg5-Atg16 complex.
In the second ubiquitin-like conjugation system, phosphatidylethanolamine is conjugated
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to Atg8/microtubule-associated protein 1 light chain 3 (LC3). Phosphatidylethanolamineconjugated LC3 is further processed by Atg4, Atg7 and Atg3 (Geng and Klionsky 2008,
Nakatogawa 2013) for the transformation of LC3Ⅰ to LC3Ⅱ. Hence, LC3Ⅱ is accepted as a
marker of autophagy (Glick, Barth et al. 2010). Autophagy is also responsible for the
cholesterol efflux in macrophages. Knocking down of autophagy related gene decreases
autophagy efflux (Ouimet, Franklin et al. 2011).

Fusion of auto-phagosomes with lysosomes
The last step of autophagy is characterized by the fusion of autophagosomes with
lysosomes to form autolysosomes and their subsequent degradation (Mizushima 2007). It
is also proposed that autophagosomes fuse with endosomes (Liou, Geuze et al. 1997) or
late endosomes (Hyttinen, Niittykoski et al. 2013) prior to fusion with lysosomes. Both
deliver cargo and the components necessary for membrane fusion machinery, and lower
the pH of autophagic vesicle. Autophagosomes that are fused with lysosomes are called
autolysosomes. This fusion is regulated by lysosomal membrane proteins Lamp1 and
Lamp2 (Tanaka, Guhde et al. 2000). In autolysosomes, the autophagic lumen is degraded
by the infusion of hydrolases and acidification through the action of proton pump provided
by lysosomes (Ishida, Nayak et al. 2013).
Autophagy is essential for the breakdown of lipid droplets in hepatocytes (Singh,
Kaushik et al. 2009). Triglyceride synthesis was measured after knocking out autophagy
related gene Atg5 by small inhibitory RNA technique in mouse embryonic fibroblast as an
indication of lipid droplet formation and free fatty acid β-oxidation. There was an
equivalent increase in the triglyceride synthesis in control and siATG5 cells after treatment
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with oleate. The rate of β-oxidation increased after lipid loading, but it decreased after
further inhibition of autophagy by 3 methyladenine (3MA). TG breakdown was also greater
in control cells than in siATG5 cells (Singh, Kaushik et al. 2009). These results suggest
that autophagy is required for lipid droplet degradation in fibroblasts.
Autophagic machinery interacts with lipid droplets during lipophagy (Singh, Kaushik
et al. 2009). A small GTPase, Rab7, mediates the docking of autophagosomes, multivesicular bodies and lysosomes during lipophagy in hepatocytes (Schroeder, Schulze et al.
2015). To mimic nutrient starvation induced activation of Rab7, a mutant GFP-tagged
Rab7 was overexpressed in cells. Increased association of multi-vesicular bodies and
lysosomes with lipid droplets was observed which was greater than the wild type GFPtagged Rab7 (Schroeder, Schulze et al. 2015).

CONCLUSION
Cholesterol burden in macrophages is a major risk factor in atherosclerosis. The idea
of autophagy has recently come into light in removing cholesterol through degradation of
lipid droplets from macrophage foam cells. Understanding this process will help to identify
effective therapeutic targets for treatment of atherosclerosis. This research is aimed at
understanding mechanisms of autophagy in lipid-laden macrophages and investigating if
there is any connection between autophagy and lipid droplet degradation or cholesterol
efflux from foam cells.
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CHAPTER TWO
LIPID-LADEN MACROPHAGES DOWNREGULATE AKT
PHOSPHORYLATION AND METABOLIZE LIPID DROPLETS VIA
AUTOPHAGY

INTRODUCTION
Plaque formation in atherosclerosis causes cardiovascular diseases like heart
attack, stroke and peripheral artery disease. Heart disease is the leading cause of death in
USA where it kills more than 600,000 people each year (Benjamin, Blaha et al. 2017).
Hence, atherosclerosis has a profound impact on public health. At present, lowering
blood cholesterol levels is the primary therapeutic strategy for treating heart disease.
However, currently available therapeutics prevent only 30% of clinical events
(Klingenberg and Hansson 2009). The high mortality rate due to heart diseases demands
investigation of the cellular nature of the disease process to enable discovery of novel
drug targets.
The primary stage of plaque initiation is the formation of macrophage foam cells.
Macrophages internalize modified low-density lipoproteins through scavenger receptors
and by other mechanisms (Brown, Goldstein et al. 1979). When viewed by microscope,
atherosclerotic plaque macrophages are found to be filled up with lipid droplets and are
called foam cells due to their appearance. Foam cell formation leads to the production of
inflammatory cytokines, proliferation and migration of smooth muscle cells and

16

narrowing of the artery wall (Buckley and Ramji 2015). After macrophages get filled up
with lipid droplets, their ability to phagocytose dead and dying cells diminishes (Szondy,
Garabuczi et al. 2014). The presence of dead cells destabilizes the plaque leading to
plaque rupture and thrombosis. Thus, targeting mechanisms to clear lipid droplets from
macrophages may be an effective way to treat atherosclerosis.
Recent work shows that autophagy and macro-autophagy promote lipid droplet
cholesterol efflux from macrophage foam cells (Ouimet, Franklin et al. 2011). Electron
microscopy characterization of the cholesterol ester cycle in murine macrophage foam
cells shows that 20% of lipid droplets are associated with specialized double membrane
structures characteristic of nascent autophagosomes (McGookey and Anderson 1983). In
another study describing cholesteryl ester accumulation in macrophages, some lipid
droplets were surrounded by classical single phospholipid bilayered membranes which
indicates the existence of lipid droplets sequestered inside of lysosomes (Brown, Ho et al.
1980). Since hydrolysis of cholesteryl esters occurs both in the cytoplasm and lysosomes,
these previous studies raise the question if autophagy delivers lipid droplets to lysosomes
for hydrolysis of cholesterol esters and contributes to the reverse cholesterol transport
process (Avart, Bernard et al. 1999).
Autophagy is activated in cells through the inhibition of the mammalian target of
rapamycin (mTOR) complex which is regulated by protein kinase B (Akt). The activated
form of Akt (pAkt) leads to the activation of mTOR which in turn phosphorylates and
inhibits ULK1 (Hahn-Windgassen, Nogueira et al. 2005, Nazio, Strappazzon et al. 2013).
Activated ULK1 induces autophagy (Russell, Tian et al. 2013) so Akt activation
ultimately leads to the inhibition of autophagy.
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Ablation of autophagy by knocking out autophagy related gene Atg5 impairs the
delivery of lipid droplets to lysosomes for lysosomal acid lipase mediated cholesteryl
ester hydrolysis in foam cells (Ouimet, Franklin et al. 2011). In contrast, autophagy is
found to deposit fatty acids in lipid droplets in fibroblast cells (Rambold, Cohen et al.
2015). Now the questions are: What is the role of autophagy in lipid droplet metabolism?
How do macrophages signal for autophagy of lipid droplets? And, what mechanisms
facilitate autophagy machinery to selectively surround lipid droplets to form
autophagosomes? Here, I test the hypothesis that formation of lipid droplets activates
autophagy in macrophages through the inhibition of Akt and its downstream signaling
pathway.

MATERIALS AND METHODS
Medium and reagents
Primary murine macrophages were differentiated and grown in bone marrow
medium (BMM). Bone marrow medium contains 20% premium inactivated fetal bovine
serum (FBS) (Atlanta Biologicals, Flowery Branch, GA), 30% L-cell conditioned
medium (Willert, Brown et al. 2003), 10,000 I.U penicillin and 10 mg/mL streptomycin
(Corning, Manassas, VA), 5.7 mM 2-mercaptoethanol (Thermo Fisher Scientific,
Waltham, MA), and Dulbecco’s Modified Eagles Medium (DMEM) containing 4.5 g/L
glucose, 0.5 g/L L-glutamine and 0.1 g/L sodium pyruvate (Corning, Manassas, VA). All
these materials were mixed together and filtered through a 0.22 μm filter (EMD
Millipore, Darmstadt, Germany).
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Bone marrow isolation from femur of mouse
Adult black 6 (C57BLJ) mice were received from Jackson Laboratories (Bar
Harbor, ME). Mice were euthanized using CO2 and femurs were harvested from the mice
carefully so that the ends of the femur remained intact (Swanson 1989). The ends of the
femur were cut off and bone marrow was flushed using DPBS without calcium or
magnesium (GE Healthcare Life Sciences, Pittsburgh, PA) using a 0.5 inch, 26-gauge
needle and 5 ml sterile Luer Lock syringe. Bone marrow was centrifuged at 800 g for 10
min. Cells were resuspended in BMM and plated at a density of 10 million cells in nontissue culture treated, sterile, 10 cm petri dishes with 10 ml of BMM. The plates were
then incubated in an incubator at 37C provided with 5% CO2. Two days later an
additional 10 ml of BMM was added to the dish. On day 4 following isolation, nonadherent cells were discarded and adherent cells were lifted from the dishes using cold
DPBS without calcium or magnesium and frozen in BMM containing 10% dimethyl
sulfoxide at a concentration of 1 x 106 cells/ml. Following a slow freeze at -80° F, cells
were stored in liquid nitrogen until use. For experiments, cell vials were taken from
nitrogen tank, thawed, and resuspended in bone marrow medium.
Formation of lipid-laden macrophages
Bone marrow macrophages were plated in non-tissue culture treated 24-well
plates and incubated for 2 h for attachment to the surface of coverslips. Cells were
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exposed to 50 µg/ml acetylated low density lipoprotein (Ac-LDL, Alfa Aeser, Haverhill,
MA) for 24 h. During this period, lipid droplets were observed to form in macrophages.
Immunofluorescence Experiment
For immunofluorescence staining, cells were fixed with 4% paraformaldehyde for
30 min, permeabilized and blocked with 2.5% bovine serum albumin 1 h. After overnight
incubation with primary antibodies (anti-LC3 and anti-adipophilin from Abcam,
Cambridge, MA, USA) cells were incubated with secondary antibodies (anti-Rabbit IgG,
DyLight488 conjugate, Invitrogen, Carlsbad, CA) for one hour. Cell nuclei were stained
with NucBlue Fixed Cell Stain Ready Probes (Thermo Fisher Scientific, Waltham, MA).
Neutral lipids were stained with Oil Red O. Before imaging, coverslips were mounted on
glass slides with Fluoromount-G (SouthernBiotech, Birmingham, AL, USA).
Western Blotting
Cells were lysed in M-PER Mammalian Protein Extraction Reagent (Thermo
Fisher Scientific, Waltham, MA). Gel electrophoresis of the total protein samples were
done in 4%-20% gradient precast gels (Mini Protean TGX gel, BioRad, Hercules, CA)
and transferred to polyvinylidene fluoride (PVDF) membrane (BioRad, Hercules, CA) for
35 min. Membranes were incubated with primary antibodies, anti phospho-Akt (Ser 473),
anti phospho-mTOR (Ser 2448) and anti phospho-ULK1 (Ser 757) to stain the
phosphorylated form of these proteins (all from Cell Signaling Technology, Danvers,
MA). Actin proteins were stained using beta-actin antibody (Mouse IgG2b, Cell
Signaling Technology, Danvers, MA) for loading control.
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Live cell imaging
Bone marrow macrophages were plated in 6 cm dishes and exposed to Ac-LDL
and Bodipy C12 red 558/568 (1 µM, Thermo Fisher Scientific, Eugene, Oregon, USA)
for 24 h. Macrophages were incubated with regular BMM for another 6 and 24 h. For
staining mitochondria and lysosomes, cells were incubated with Mitotracker green
(100nM, ThermoFisher Scientific, Eugene, Oregon, USA) or Lyso Tracker green (50nM,
ThermoFisher Scientific, Eugene, Oregon, USA) for 30 min prior to imaging. Images
were acquired by an Andromeda spinning disk confocal microscope.
Electron microscopy
Bone marrow macrophages were exposed to Ac-LDL (50 µg/ml) for 24 h.
Medium was replaced by fresh bone marrow medium for 4, 24 and 48 h. Cells were
centrifuged and fixed in 2% glutaraldehyde in 4% PFA. Cells were micro-centrifuged and
post-fixed in 1% osmium tetroxide. Dehydration was done by using ethanol with
increasing concentrations. After embedding in propylene oxide, polymerization was done
at 60C for overnight. Ultra-thin sections (50-70 nm) were made using an
ultramicrotome.
Imaging
For fixed cells on the coverslips images were acquired using an EVOS FL
imaging system containing GFP, CY5, DAPI filter cubes (ThermoFisher Scientific,
Waltham, MA). An Andromeda spinning disk confocal microscope was used for the
acquisition of live cell images. The 561nm laser with Zet 442/514/561x excitation wheel
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and 605/64 emission wheel were used for “red.” The 445 lasers with Zet 442/514/561x
excitation wheel and 537/26 emission wheel were used for “green.”
Image Analysis
ImageJ (National Institutes of Health, Bethesda, MA) (Schneider, Rasband et al.
2012) and Cell Profiler (Carpenter, Jones et al. 2006) were used to process images and
quantify raw data. All raw images were visualized, cropped, and processed into montages
using ImageJ. Data quantification was done using Cell Profiler. For measuring
fluorescence intensity in cell profiler, a pipeline was constructed with different modules.
For subtracting background, total image intensity was measured and lower quartile
intensity was subtracted from the total image intensity. Nuclei were identified as primary
objects using automatic threshold strategy and other proteins stained with antibody were
identified as secondary objects using propagation method. The same proteins stained
were used to train cell profiler to find the edge of the cell. Finally, object intensity was
measured based on identified primary and secondary objects.
Statistical Analysis
Statistical analyses were done using GraphPad Prism software version 6 (GraphPad
Software, Inc, La Jolla, CA). Values are given as mean fluorescence intensity (n = 2-3
coverslips/timepoint, 60-100 cells/coverslip). Absent error bars in the bar graphs signify
the values smaller than the graphic symbols. Statistical analysis was carried out using
one-way ANOVA and two-way ANOVA. Tukey’s multiple comparison test and HolmSidak’s test were performed for post hoc comparison of means. P-values less than 0.05
were considered significant.
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RESULTS
Macrophage lipid droplets are degraded following Ac-LDL removal from culture
medium
We exposed bone marrow macrophages to Ac-LDL for 24 h to load cells with
lipid droplets. Then, Ac-LDL was removed and lipid droplet abundance was monitored in
cells in growth medium for 4, 24 or 48 h (Fig. 1) to see if lipid droplets are stable in cells.
Oil Red O was used to stain lipid droplets. Fluorescent microscopy images show that 4,
24 and 48 h after Ac-LDL removal from medium, the mean integrated intensity of Oil
Red O decreased compared to 0 h (p < 0.05; Fig. 2). This result suggests that lipid
droplets in lipid-laden macrophages are quickly degraded following a decrease in the
cholesterol availability in the cellular environment.
Lipid droplet associated proteins appear as circular, ring-like structures
surrounding lipid droplets.
Lipid droplets are ubiquitous organelles found in almost all organisms including
humans, yeast, and bacteria. The surface of lipid droplets is decorated with many proteins
some of which are shared by other organelles. Proteins exclusive to lipid droplets are
known as PAT (perilipins, adipophilins and TIP47s or tail-interacting protein 47 KD)
(Bickel, Tansey et al. 2009). Adipophilin deletions in 𝐴𝑝𝑜𝐸−/− mice caused reduced
lipid droplet formation in macrophages which suggests that adipophilin is important for
the formation of foam cells (Paul, Chang et al. 2008). To get some idea about adipophilin
presence on lipid droplets during lipid droplet degradation, cellular adipophilin was
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immunostained with anti-ADFP antibody and a fluorescent secondary antibody. After
staining lipid droplets with Oil Red O, we found ring-like structures of adipophilin on the
edges of lipid droplets (Fig 3). Pixel intensities from lines drawn on the image show
adipophilin rings at early and late time points (Fig 3B-E). The disappearance of
adipophilin rings correlates with the disappearance of lipid droplets (Fig 3A).
The autophagosomal marker protein, LC3, decreases within 24 h after Ac-LDL
removal from medium.
The LC3 conjugation system is required for the formation of autophagosomes
(Kabeya, Mizushima et al. 2000). Cytosolic LC3-Ⅰ is conjugated with
phosphatidylethanolamine (PE) to make the membrane bound form of LC3-Ⅱ. LC3-Ⅱ is
located on pre-autophagosomes and autophagosomes after their formation and thus is
used as a marker of autophagosomes (Kabeya, Mizushima et al. 2000). To investigate if
autophagosomes are formed in foam cells after removal of Ac-LDL from the culture
medium, we stained LC3 proteins with anti-LC3 antibody (Figure 4A). One-way
ANOVA and Tukey’s post hoc comparison show that following Ac-LDL removal from
the culture medium, LC3 expression is decreased at 24 h compared to 0 h (p<0.05; Fig.
4B).
Inhibition of the formation of autophagy machinery reduces lipid droplet clearance
from macrophages.
In previous experiments, we found that lipid droplets are not permanent in foam
cells. In the absence of Ac-LDL, lipid droplets are degraded starting within 24 h of LDL
removal. If autophagy contributes to the metabolism of lipid droplets, then inhibiting the
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formation of autophagosomes will prevent lipid droplet metabolism. Therefore, more
lipid droplets are expected following removal of Ac-LDL from the culture medium if
autophagosomes formation is inhibited. Autophagosome formation was inhibited by 3methyl adenine (3MA), which inhibits the class Ⅲ PI3K complex that is required for the
formation of autophagosomes (Seglen and Gordon 1982). Lipid-laden macrophages were
exposed to 3MA for 24-48 h after removal of Ac-LDL from the culture medium. Oil Red
O staining of lipid droplets show that there are more lipid droplets at 48 h time point in
3MA inhibited cells compared to untreated cells (Fig 5A). The average fluorescence
intensity of Oil Red O staining/cell was measured using Cell Profiler and graphed. Twoway ANOVA and Holm-Sidak post hoc comparison of means reveals that there is a
greater average fluorescence intensity of 48 h, 3MA treated cells compared to control
cells (p<0.05) (Fig 5B).
Induction of autophagy does not affect lipid droplets disappearance from
macrophages.
The role of autophagy in macrophage lipid metabolism demands more
investigation. So, we used rapamycin, a pharmaceutical drug, to induce autophagy in
macrophages and see if degradation of lipid droplets is hampered due to the induction of
autophagy. Rapamycin is a drug that targets the mTOR pathway to inhibit growth
signaling and promote autophagy. Lipid-laden bone marrow macrophages were treated
with 5 nM rapamycin in bone marrow medium for 4, 24 or 48 h. Immunofluorescence
staining of LC3 with anti-LC3 antibody shows the same fluorescence pattern as control
cells with lipid droplet size and abundance decreasing over time indicating that
promoting autophagy had no effect on the rate of lipid droplet metabolism (Fig. 6A).
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Total fluorescence intensity per cell was measured by ImageJ. Two-way ANOVA and
Holm-Sidak post hoc comparison of means shows that there is no significant difference
of the fluorescence intensities between rapamycin treated and untreated cells, which
suggests that induction of autophagy does not affect lipid droplet disappearance from
macrophages (Fig 6B).
Inhibition of autophagy with 3MA during Ac-LDL treatment does not affect the
formation of lipid droplets.
In fibroblast cells, previous work in fibroblasts found autophagy deposits fatty
acids into lipid droplets (Rambold, Cohen et al. 2015). This raises questions whether
autophagy has a role of autophagy in lipid droplet formation. The objective of this
experiment was to see if lipid droplet formation is prevented in the absence of autophagy.
Bone marrow macrophages were treated with 50ug/mL Ac-LDL for 4 and 24 with or
without 3MA. Staining of lipid droplets with Oil Red O shows that there is no phenotypic
difference between control and 3MA treated cells in lipid droplet accumulation.
Immunofluorescence staining of LC3 was done as a marker of autophagosomes (Fig 7A).
Total fluorescence integrated intensity was measured using CellProfiler. Even though
quantified result shows a slight decrease of Oil Red O fluorescence in 3MA treated cells,
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Two-way ANOVA and Holm-Sidak’s post hoc comparison reveals that there is no
significant difference between control and treated cells (Fig 7B).
Fatty acids localize to lysosomes but not mitochondria during lipid droplet
degradation.
We designed a live-cell imaging experiment to stain fatty acids and mitochondria or
lysosomes to see if lipid droplets are used as the source of β- oxidation or if they are
going to lysosomes for cholesterol efflux. If lipid droplets were a source of fatty acids for
beta oxidation in the mitochondria, then Bodipy C12 Red and Mitotracker would be colocalized during lipid droplet degradation. However, none was seen (Fig. 8). This result
suggests that Ac-LDL induced lipid droplets are not utilized by mitochondria for beta
oxidation. The result from lysosomal staining shows that before removing Ac-LDL from
medium (0 h) fatty acids are in lysosomes (Fig 9B). This could be because fatty acids
components of lipid droplets (triglycerides) trafficked through lysosomes prior to
deposition in lipid droplets. Six hours following Ac-LDL removal, fatty acids have left
lysosomes (Fig 9A) and after 24 h they are found in close proximity of lysosomes (Fig
9C). Fatty acids look surrounded by lysosomes and this may provide evidence that fatty
acids traffic through lysosomes during lipid droplet formation as well as degradation.
Furthermore, the close proximity of fatty acids and lysosomes during lipid droplet
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degradation provides evidence to support the role of autophagy in the degradation of lipid
droplets.
Phosphorylation of Akt is decreased during the formation and degradation of lipid
droplets.
Since autophagy starts when cells are lipid loaded, we were interested to see if
exposure to Ac-LDL or presence of lipid droplets changes growth-factor signaling in
macrophages. Akt is a protein required for the growth of cells which activates the mTOR
signaling pathway. Phosphorylated mTOR inhibits autophagy by phosphorylating and
inhibiting unc-51-like kinase 1 (ULK1). Lipid-laden macrophages were immunostained
for activated Akt (pAkt) during the formation of lipid droplets and 4 h following the
removal of Ac-LDL from the culture medium (Fig 10A). Phosphorylation of Akt was
lower in Ac-LDL cells compared to untreated cells at the -4, 0 and 4-h timepoints
(p<0.05, one-way ANOVA and Holm-Sidak’s post hoc comparison of means) (Fig 10B).
To further clarify this, we immunoblotted for pAkt, pmTOR and pULK1 to see how this
pathway is affected by lipid droplet formation in macrophages. Immunoblot result shows
slight different result from immunofluorescence staining of pAkt (Fig. 11). pAkt signal
was reduced after the formation of lipid droplets in macrophages. On the other hand,
pmTOR signal increases after Ac-LDL treatment which decreases after Ac-LDL removal
(Fig 11). Similarly, pULK1 is also increased after Ac-LDL treatment as well, but start to
decrease with the formation of lipid droplets (Fig 11).
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Transmission electron microscopy shows double membrane organelles surrounding
lipid droplets after formation of lipid droplets and 4 h after Ac-LDL removal from
macrophages.
Bone marrow macrophages were treated with AC-LDL for 24 h and replaced with
bone marrow medium for 0, 4 and 24 h and fixed. This was done to look for double
membrane organelles surrounding lipid droplets to make sure about autophagy. In
electron microscopy images, double membrane structure was found surrounding lipid
droplets after formation of foam cells (0 h) and within 4 h of AC-LDL removal from
culture medium (Fig 12).

DISCUSSION
Here we present evidence that autophagy facilitates the degradation of lipid
droplets in Ac-LDL exposed macrophages. Lipid droplets made following Ac-LDL
exposure are quickly degraded in macrophages after withdrawal of LDL. However, this
degradation is inhibited in the presence of the PI3K inhibitor 3-MA. Furthermore, double
lipid bilayers are seen on lipid droplets in macrophages and live-cell microscopy shows
trafficking of fatty acids to lysosomes during lipid droplet degradation. Akt
phosphorylation is decreased in lipid-laden macrophages compared to controls. Lowered
activation of Akt may be a mechanism for the induction of autophagy in lipid-laden
macrophages.
In exploring lipid droplet degradation in macrophages, we found that after
formation of foam cells, lipid droplets get digested in the absence of Ac-LDL in the
culture medium. Previous study also shows that autophagy is activated after lipid loading
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in macrophages (Ouimet, Franklin et al. 2011). From this point of view, we stained
LC3II. LC3II is extensively used as a marker of autophagosomes. Accumulation of LC3II
is one line of evidence supporting autophagy. Lipid droplet stained with Bodipy C12 Red
were also found near lysosomes which correlates with the idea of lysosomes docking to
lipid droplets during lipid droplet degradation through autophagy in hepatocytes
(Schroeder, Schulze et al. 2015).
Reduced pAkt and pULK1 signal is another evidence supporting the idea of
autophagy induction after foam cell formation. Increased pmTOR signal during the
formation of lipid droplets is somewhat confusing which may indicate that autophagy is
activated in a mTOR independent pathway. When mTOR is activated or phosphorylated,
it inhibits autophagy by phosphorylating ULK1. The presence of pULK1 means it’s
inhibited. On the other hand, absence of pULK1 means ULK1 as well as autophagy is
active. We got reduced signal of pULK1 at 4 h which indicates that autophagy is active
even though mTOR is activated at the same time. This will be interesting to investigate
how pULK1 is reduced in the presence activated mTOR and if inhibition of Akt
phosphorylation reduces lipid droplets get degradation or not.
In conclusion, Ac-LDL treatment or lipid droplet formation induces autophagy in
lipid-laden macrophages through inhibition of phosphorylation of Akt and activation of
ULK1. Autophagy then delivers lipid droplets to lysosomes for degradation. However,
autophagy is not important for the formation of lipid droplets in macrophages.
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Lipid droplet degradation
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Figure 1. Experimental timeline of Ac-LDL induced formation of lipid-laden macrophages and lipid droplet degradation.
Lipid-laden macrophages were made by treating bone marrow or fetal liver macrophages with acetylated low-density lipoproteins (Ac-LDL)
for 24 h. To follow their degradation, Ac-LDL media was replaced with fresh media and incubated for 0, 4, 24 and 48 h and fixed.
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Figure 2. Macrophage lipid droplets are degraded following Ac-LDL removal from culture medium. Bone marrow macrophages were
loaded with lipid droplets by culturing with Ac-LDL for 24 h. Ac-LDL medium was replaced with bone marrow media when all the cells were
filled up with lipid droplets. Cells were incubated with bone marrow medium for 4, 24 and 48 h and then fixed. A) Images from epifluorescence
microscope show lipid droplets labelled with Oil Red O and nuclei labelled with DAPI, B) Total fluorescence intensity of Oil Red O was
measured using Image J and graphed. Error bars show standard deviations. Different letters represent statistical differences, p< 0.05. n = 3
coverslips/timepoint (~100 cells/coverslips). LD = Lipid droplets.
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Figure 3. Adipophilins form ring-like structure surrounding lipid droplets and remain associated with them during metabolism. Lipid droplet
associated protein, adipophilin, was stained with anti-ADFP antibody. A) Immunofluorescence staining of ADFP showing the ring structures surrounding
lipid droplets. Images were taken from inverted microscope with oil objective, B) Inset from A at 4 h (white box), C) Gray value/pixel intensity was
measured along the line in lipid droplets and ADFP images and graphed, D) Inset from A at 48 h (white box), E) Gray value/pixel intensity was measured
along the line in lipid droplets and ADFP images and graphed. LD = Lipid droplets.
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Figure 4. LC3-II decreases within 24 h after Ac-LDL removal from culture medium. Cells were fixed at 0, 4, 24 and 48 h following AcLDL removal from medium. Images were taken by epifluorescence microscope. A) Immunostaining of LC3-II (green) and Oil Red O
staining of lipid droplets (red), B) Mean fluorescence intensity of LC3-II. Error bars show standard deviations. LD = Lipid droplets.
Different letters represent statistical difference p< 0.05. n = 3 coverslips/timepoint (~100 cells/coverslips)
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Figure 5. Cells have more lipid droplets after 48 h of 3MA treatment compared to control cells.
A) Lipid droplets were stained with Oil Red O in control and 3MA treated lipid-laden macrophages following Ac-LDL removal from the culture
medium. B-D) Integrated fluorescence intensity of lipid droplet fluorescence was measured using Cell Profiler and graphed as percent 0-h control
cells. Error bars represent standard deviations. N= 2-3 fields of view (60 cells) B) Experiment 1, C) Experiment 2 and D) Averages from two
experiments. ****p≤.0001, ***p≤.001, **p≤.01, *p≤.05
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Figure 6. Induction of autophagy does not prevent lipid droplet disappearance from cells.
Cells were treated (w/wo Rapamycin) for 0, 4, 24 and 48 h after Ac-LDL removal. A) Images from inverted microscope show lipid
droplets stained with Oil Red O. B) Mean fluorescence intensity of Oil Red O was measured in Cell Profiler and graphed. Error bars are
showing standard deviations. N= 2 coverslips (~100 cells/coverslip).
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Figure 7. Inhibition of autophagy by 3MA does not affect the formation of lipid droplets.
Cells were treated (w/wo 3MA) for 4 and 24 h during the treatment with Ac-LDL. A) Images from fluorescence microscope show lipid droplets stained
with Oil red O. B) Mean fluorescence intensity of Oil Red O was measured in Cell Profiler and averages of two independent experiments are graphed.
Error bars show standard deviation. N= 2 coverslips (~100 cells/coverslip).
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Figure 8. Fatty acids do not localize in mitochondria after 24 h.
Bone marrow macrophages were incubated with Ac-LDL and BODIPY C12 Red (a market for fatty acids) for 24 h. Cells
were incubated for another 1 h with bone marrow media so that all the C12 red enters lipid droplets. Then cells were
incubated with complete media for 6 and 24 h and imaged by spinning disk confocal microscope to determine subcellular
localization of fatty acids. Mitochondria were labelled with Mito Tracker Green. FA = Fatty acids.
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Figure 9. Fatty acids do not localize in lysosomes after 24 h of Ac-LDL removal from macrophages.
Bone marrow macrophages were incubated with Ac-LDL and BODIPY C12 Red for 24 h. Cells were incubated for another 1 hour with
complete media so that all the C12 red enters lipid droplets. A) Then cells were incubated with bone marrow media for 6 and 24 h and
imaged by spinning disk confocal microscope to determine subcellular localization of fatty acids. Lysosomes were labelled with Lyso
Tracker Green. B) Inset of A from 0 h row (white box), C) Inset of A from 24 h row (white box). FA = Fatty acids.
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Figure 10. pAkt decreases during Ac-LDL treatment, formation of lipid droplets, and during their degradation.
Bone marrow macrophages were treated with Ac-LDL (50 µg/mL) for 4 and 24 h and fixed. For some cells Ac-LDL media was replaced by fresh bone
marrow media for another 4 h and fixed. Immunofluorescence staining of pAkt was done using anti-pAkt primary antibody. Lipid droplets were
stained with Oil Red O. B) Mean fluorescence intensity of pAkt was measured using image j and graphed. Different letters are representing statistical
differences. Error bars are showing standard deviations. N= 1 coverslips (40 cells)
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Figure 11. Western blot with three important proteins in autophagy signaling pathway.
A) Western blot images of pAkt, pmTOR and pULK1, B) Quantification of pAkt band intensity, C) pmTOR band intensity, D) pULK1 band
intensity.
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CHAPTER THREE
CONCLUSION

Lipid-laden macrophages are the key mediators of the plaque formation in
atherosclerosis. Macrophages become lipid-laden by internalizing modified low-density
lipoproteins and storing them in lipid droplets. They are known as foam cells because of
their foamy appearance viewed by microscope. In macrophages, neither the mechanisms
of lipid droplet formation nor the mechanisms of lipid droplet degradation are well
understood. It is important to understand these basic processes to identify therapeutic
targets for the treatment of atherosclerosis. The goal of this project was to understand the
role of autophagy in lipid droplet clearance from macrophages. Investigation into
signaling and trafficking mechanisms of autophagic clearance from macrophage lipid
droplets will help us to design therapeutics to treat atherosclerosis.
Autophagy is a cellular process used for degrading cellular components for
energy production which is found to play an important role in the degradation of lipid
droplets in hepatocytes (Schroeder, Schulze et al. 2015). In this process, autophagosomes
are formed surrounding cellular components for delivery to lysosomes for degradation.
However, how this process is activated in macrophages following lipid droplet formation
is not clearly understood. Similarly, how lipid droplets signal for autophagy and which
proteins are involved in this process still needs to be investigated. Furthermore, it is
important to study lipid droplet associated proteins to see if any of them are part of
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autophagy signaling process. Studying adipophilin will be a good start to look for the
lipid droplet associated proteins that facilitate lipid droplet degradation in macrophages.
Following lipid droplet formation in macrophages, autophagy quickly degrades
lipid droplets. Lipid droplet metabolism can be prevented by the inhibition of
autophagosome formation. We found the lipid droplets in macrophages are not used as a
source of β-oxidation, rather they are degraded by lysosomes for cholesterol efflux. There
is also some effect of lipid droplet formation on phosphorylation of Akt. Exposure to
acetylated LDL or the presence of lipid droplets may cause inhibition of phosphorylation
of Akt or may increase the rate of Akt dephosphorylation by phosphatases. Increased
mTOR signal in the presence of decreased pAkt signal may suggest that this activation of
autophagy is mTOR independent (Fig 13).
In this study, acetylated LDL was used to form lipid droplets since it is processed
quickly. However, it is not found in vivo and there are some debates how its metabolism
in cell differ. It will be worthwhile to perform these experiments with oxidized LDL
instead of acetylated to see if treatment of oxidized LDL or the presence of lipid droplets
triggers autophagy in the same that Acetylated LDL does.
To further study signaling events, inhibiting the Akt signaling pathway and
monitoring lipid droplet degradation will be worthwhile to see if Akt has any effect on
lipid droplet degradation as well as autophagy.
Understanding the mechanism of lipid droplet metabolism and underlying
signaling events will bring the novel therapeutic strategies that reduce the lipid burden in
atherosclerotic plaques. The data I collected will be helpful to further research efforts
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leading to developing therapeutic strategies targeting foam cell macrophages to treat
atherosclerosis.
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